This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Molenaar, J. J. Articles by Caron, H. N. Search for Related Content PubMed PubMed Citation Articles by Molenaar, J. J. Articles by Caron, H. N.

Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma

¹ Departments of Human Genetics and ² Pediatric Oncology, Emma Kinderziekenhuis, and ³ Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

Requests for reprints: Jan J. Molenaar, Department of Human Genetics, AMC, M1-132, Meibergdreef 15, 1105 AZ Amsterdam, the Netherlands. Phone: 31-20-5667536; Fax: 31-20-6918626; E-mail: j.j.molenaar{at}amc.uva.nl.

Key Words: Cyclin D1 • CDK4 • Neuroblastoma • RNA interference • Differentiation

Genomic aberrations of Cyclin D1 (CCND1), CDK4, and CDK6 in neuroblastoma indicate that dysregulation of the G₁ entry checkpoint is an important cell cycle aberration in this pediatric tumor. Here, we report that analysis of Affymetrix expression data of primary neuroblastic tumors shows an extensive overexpression of Cyclin D1, which correlates with histologic subgroups. Immunohistochemical analysis showed overexpression of Cyclin D1 in neuroblasts and low Cyclin D1 expression in all cell types in ganglioneuroma. This suggests an involvement of G₁-regulating genes in neuronal differentiation processes which we further evaluated using RNA interference against Cyclin D1 and its kinase partners CDK4 and CDK6 in several neuroblastoma cell lines. The Cyclin D1 and CDK4 knockdown resulted in pRb pathway inhibition as shown by an almost complete disappearance of CDK4/CDK6-specific pRb phosphorylation, reduction of E2F transcriptional activity, and a decrease of Cyclin A protein levels. Phenotype analysis showed a significant reduction in cell proliferation, a G₁-specific cell cycle arrest, and, moreover, an extensive neuronal differentiation. Affymetrix microarray profiling of small interfering RNA–treated cells revealed a shift in expression profile toward a neuronal phenotype. Several new potential downstream players are identified. We conclude that neuroblastoma functionally depend on overexpression of G₁-regulating genes to maintain their undifferentiated phenotype. [Cancer Res 2008;68(8):2599–609]

This article has been cited by other articles:

				J. J. Molenaar, M. E. Ebus, D. Geerts, J. Koster, F. Lamers, L. J. Valentijn, E. M. Westerhout, R. Versteeg, and H. N. Caron Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells PNAS, August 4, 2009; 106(31): 12968 - 12973. [Abstract] [Full Text] [PDF]

				E. A. Klein and R. K. Assoian Transcriptional regulation of the cyclin D1 gene at a glance J. Cell Sci., December 1, 2008; 121(23): 3853 - 3857. [Full Text] [PDF]